Post-marketing study on the safety of a meningococcal group A, C bivalent polysaccharide conjugate vaccine

被引:1
|
作者
Fu, Chuanxi [1 ]
Huang, Guihua [1 ]
Cui, Min [1 ]
Wang, Ming [1 ]
机构
[1] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China
关键词
meningococcal meningitis; vaccine; safety; China; adverse reactions; DISEASE;
D O I
10.4161/hv.26347
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
下载
收藏
页码:138 / 139
页数:2
相关论文
共 50 条
  • [41] CONTROL OF AN OUTBREAK OF GROUP-C MENINGOCOCCAL MENINGITIS WITH A POLYSACCHARIDE VACCINE
    MASTERTON, RG
    YOUNGS, ER
    WARDLE, JCR
    CROFT, KF
    JONES, DM
    JOURNAL OF INFECTION, 1988, 17 (02) : 177 - 182
  • [42] Safety and immunogenicity of meningococcal C conjugated (MenC) vaccine in toddlers previously immunized with meningococcal polysaccharide (MenPS) vaccine
    MacDonald, NE
    Halperin, S
    Law, B
    Danzig, L
    Granoff, D
    PEDIATRIC RESEARCH, 1999, 45 (04) : 167A - 167A
  • [43] Moderate PEGylation of the carrier protein improves the polysaccharide-specific immunogenicity of meningococcal group A polysaccharide conjugate vaccine
    Zhang, Tingting
    Yu, Weili
    Wang, Yanfei
    Hu, Tao
    VACCINE, 2015, 33 (28) : 3208 - 3214
  • [44] Meningococcal group A, C, Y and W-135 conjugate vaccine
    Lee H. Harrison
    Nitin Mohan
    Peter Kirkpatrick
    Nature Reviews Drug Discovery, 2010, 9 : 429 - 430
  • [45] Meningococcal group A, C, Y and W-135 conjugate vaccine
    Harrison, Lee H.
    Mohan, Nitin
    Kirkpatrick, Peter
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (06) : 429 - 430
  • [46] Meningococcal serogroup C conjugate vaccine
    Lakshman, R
    Finn, A
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (01) : 87 - 96
  • [47] Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and Lessons
    Enwere, Godwin C.
    Paranjape, Gandhali
    Kulkarni, Prasad S.
    Ginde, Manisha
    Hartmann, Katharina
    Viviani, Simonetta
    Chaumont, Julie
    Martellet, Lionel
    Makadi, Marie-Francoise
    Ivinson, Karen
    Marchetti, Elisa
    Herve, Jacques
    Kertson, Kim
    LaForce, F. Marc
    Preziosi, Marie-Pierre
    CLINICAL INFECTIOUS DISEASES, 2015, 61 : S501 - S506
  • [48] Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans
    Sow, Samba O.
    Okoko, Brown J.
    Diallo, Aldiouma
    Viviani, Simonetta
    Borrow, Ray
    Carlone, George
    Tapia, Milagritos
    Akinsola, Adebayo K.
    Arduin, Pascal
    Findlow, Helen
    Elie, Cheryl
    Haidara, Fadima Cheick
    Adegbola, Richard A.
    Diop, Doudou
    Parulekar, Varsha
    Chaumont, Julie
    Martellet, Lionel
    Diallo, Fatoumata
    Idoko, Olubukola T.
    Tang, Yuxiao
    Plikaytis, Brian D.
    Kulkarni, Prasad S.
    Marchetti, Elisa
    LaForce, F. Marc
    Preziosi, Marie-Pierre
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2293 - 2304
  • [49] The role of economic evaluation in vaccine decision makingFocus on meningococcal group C conjugate vaccine
    Robert Welte
    Caroline L. Trotter
    W. John Edmunds
    Maarten J. Postma
    Philippe Beutels
    PharmacoEconomics, 2005, 23 : 855 - 874
  • [50] Prior meningococcal A/C polysaccharide vaccine does not reduce immune responses to conjugate vaccine in young adults
    Lakshman, R
    Burkinshaw, R
    Choo, S
    Finn, A
    VACCINE, 2002, 20 (31-32) : 3778 - 3782